Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: December 1 2002, Volume 1, Issue 14   [Index by Author]  [Cover Caption]
       Articles
       Minireview
       Erratum
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Steffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison, Richard J. Bold, Bridget Sweeney Gotsch, James L. Abbruzzese, Peter Elliott, Julian Adams, and David J. McConkey
Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts
Mol Cancer Ther 2002 1: 1243-1253. [Abstract] [Full Text] [PDF]  

Manas K. Pathak, Deepika Dhawan, Daniel J. Lindner, Ernest C. Borden, Carol Farver, and Taolin Yi
Pentamidine Is an Inhibitor of PRL Phosphatases with Anticancer Activity
Mol Cancer Ther 2002 1: 1255-1264. [Abstract] [Full Text] [PDF]  

Abhijit G. Banerjee, Velliyur K. Gopalakrishnan, Indraneel Bhattacharya, and Jamboor K. Vishwanatha
Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues
Mol Cancer Ther 2002 1: 1265-1271. [Abstract] [Full Text] [PDF]  

Matthew J. Grimshaw, Stuart Naylor, and Frances R. Balkwill
Endothelin-2 Is a Hypoxia-induced Autocrine Survival Factor for Breast Tumor Cells
Mol Cancer Ther 2002 1: 1273-1281. [Abstract] [Full Text] [PDF]  

Thomas R. Sutter, Xiao-Rui He, Peter Dimitrov, Lijing Xu, Giri Narasimhan, E. Olusegun George, Carrie Hayes Sutter, Clinton Grubbs, Richard Savory, Markus Stephan-Gueldner, Dirk Kreder, Michael J. Taylor, Ronald Lubet, Tricia A. Patterson, and Thomas W. Kensler
Multiple Comparisons Model-based Clustering and Ternary Pattern Tree Numerical Display of Gene Response to Treatment: Procedure and Application to the Preclinical Evaluation of Chemopreventive Agents
Mol Cancer Ther 2002 1: 1283-1292. [Abstract] [Full Text] [PDF]  

Paul H. Johnson, Roger P. Walker, Steven W. Jones, Kathy Stephens, Janet Meurer, Deborah A. Zajchowski, May M. Luke, Frank Eeckman, Yuping Tan, Linda Wong, Gordon Parry, Thomas K. Morgan, Jr., Meg A. McCarrick, and Joseph Monforte
Multiplex Gene Expression Analysis for High-Throughput Drug Discovery: Screening and Analysis of Compounds Affecting Genes Overexpressed in Cancer Cells
Mol Cancer Ther 2002 1: 1293-1304. [Abstract] [Full Text] [PDF] Supplementary Data  

Jose M. Minguez, Kenneth A. Giuliano, Raghavan Balachandran, Charitha Madiraju, Dennis P. Curran, and Billy W. Day
Synthesis and High Content Cell-based Profiling of Simplified Analogues of the Microtubule Stabilizer (+)-Discodermolide
Mol Cancer Ther 2002 1: 1305-1313. [Abstract] [Full Text] [PDF]  

Edith J. Mensah-Osman, Ayad M. Al-Katib, Mahmoud H. Dandashi, and Ramzi M. Mohammad
2-[4-(7-Chloro-2-quinoxalinyloxy)phenoxy]-propionic Acid (XK469) Inhibition of Topoisomerase IIß Is Not Sufficient for Therapeutic Response in Human Waldenstrom’s Macroglobulinemia Xenograft Model
Mol Cancer Ther 2002 1: 1315-1320. [Abstract] [Full Text] [PDF]  

Edith J. Mensah-Osman, Ayad M. Al-Katib, Hai-Young Wu, Nadir I. Osman, and Ramzi M. Mohammad
2-[4-(7-Chloro-2-quinoxalinyloxy)phenoxy]-propionic Acid (XK469), an Inhibitor of Topoisomerase (Topo) IIß, Up-Regulates Topo II{alpha} and Enhances Topo II{alpha}-mediated Cytotoxicity
Mol Cancer Ther 2002 1: 1321-1326. [Abstract] [Full Text] [PDF]  

Atsuko Kanzaki, Yuji Takebayashi, Xiao-Qin Ren, Hitoshi Miyashita, Shiro Mori, Shin-ichi Akiyama, and Yves Pommier
Overcoming Multidrug Drug Resistance in P-Glycoprotein/MDR1-overexpressing Cell Lines by Ecteinascidin 743
Mol Cancer Ther 2002 1: 1327-1334. [Abstract] [Full Text] [PDF]  

Liandong Ma, Susan E. Pratt, Jin Cao, Anne H. Dantzig, Robert E. Moore, and Christopher A. Slapak
Identification and Characterization of the Canine Multidrug Resistance-associated Protein
Mol Cancer Ther 2002 1: 1335-1342. [Abstract] [Full Text] [PDF]  

WeiWei Li and Joseph R. Bertino
Fas-mediated Signaling Enhances Sensitivity of Human Soft Tissue Sarcoma Cells to Anticancer Drugs by Activation of p38 Kinase
Mol Cancer Ther 2002 1: 1343-1348. [Abstract] [Full Text] [PDF]  

Judith Hailey, Eugene Maxwell, Kathy Koukouras, W. Robert Bishop, Jonathan A. Pachter, and Yan Wang
Neutralizing Anti-Insulin-like Growth Factor Receptor 1 Antibodies Inhibit Receptor Function and Induce Receptor Degradation in Tumor Cells
Mol Cancer Ther 2002 1: 1349-1353. [Abstract] [Full Text] [PDF]  

Jung-Sik Kim, Heather Crooks, Aaron Foxworth, and Todd Waldman
Proof-of-Principle: Oncogenic ß-Catenin Is a Valid Molecular Target for the Development of Pharmacological Inhibitors
Mol Cancer Ther 2002 1: 1355-1359. [Abstract] [Full Text] [PDF]  

Minireview:

Kenneth C. Anderson and William S. Dalton
Synopsis of a Research Roundtable Presented on Cell Signaling in Myeloma: Regulation of Growth and Apoptosis—Opportunities for New Drug Discovery
Mol Cancer Ther 2002 1: 1361-1365. [Abstract] [Full Text] [PDF]  

Erratum:

Erratum
Mol Cancer Ther 2002 1: 1366. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.